ASPRUZYO Trademark

Trademark Overview

On Wednesday, July 22, 2020, a trademark application was filed for ASPRUZYO with the United States Patent and Trademark Office. The USPTO has given the ASPRUZYO trademark a serial number of 90067188. The federal status of this trademark filing is REGISTERED as of Tuesday, September 20, 2022. This trademark is owned by Sun Pharma Global FZE. The ASPRUZYO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular disease
aspruzyo

General Information

Serial Number90067188
Word MarkASPRUZYO
Filing DateWednesday, July 22, 2020
Status700 - REGISTERED
Status DateTuesday, September 20, 2022
Registration Number6853072
Registration DateTuesday, September 20, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 19, 2020
Primary Code005
First Use Anywhere DateTuesday, July 19, 2022
First Use In Commerce DateTuesday, July 19, 2022

Trademark Owner History

Party NameSun Pharma Global FZE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSharjah
AE
Party NameSun Pharma Global FZE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSharjah
AE
Party NameSun Pharma Global FZE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSharjah
AE

Trademark Events

Event DateEvent Description
Tuesday, September 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 20, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, September 7, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 16, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 15, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, August 13, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 4, 2022USE AMENDMENT FILED
Saturday, August 13, 2022SOU EXTENSION 3 GRANTED
Thursday, August 4, 2022SOU EXTENSION 3 FILED
Saturday, August 13, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 4, 2022TEAS EXTENSION RECEIVED
Thursday, August 4, 2022TEAS STATEMENT OF USE RECEIVED
Friday, February 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 9, 2022SOU EXTENSION 2 GRANTED
Wednesday, February 9, 2022SOU EXTENSION 2 FILED
Wednesday, February 9, 2022TEAS EXTENSION RECEIVED
Saturday, July 31, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 29, 2021SOU EXTENSION 1 GRANTED
Thursday, July 29, 2021SOU EXTENSION 1 FILED
Thursday, July 29, 2021TEAS EXTENSION RECEIVED
Tuesday, February 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 5, 2020ASSIGNED TO EXAMINER
Wednesday, August 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 25, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

aspruzyo disease cardiovascular treatment preparations pharmaceutical